International Expert Consensus on Switching Platelet P2Y12 Receptor-Inhibiting Therapies.

• Angiolillo DJ Division of Cardiology, University of Florida College of Medicine, Jacksonville (D.J.A., F.R., F.F.). dominick.angiolillo@jax.ufl.edu.
• Rollini F Division of Cardiology, University of Florida College of Medicine, Jacksonville (D.J.A., F.R., F.F.).
• Storey RF Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, United Kingdom (R.F.S.).
• Bhatt DL Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, MA (D.L.B.).
• James S Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Sweden (S.J.).
• Schneider DJ Department of Medicine, Cardiology Unit, Cardiovascular Research Institute, University of Vermont, Burlington (D.J.S.).
• Sibbing D Department of Cardiology, Ludwig-Maximilians-Universität München, Germany (D.S.).
• So DYF Division of Cardiology, University of Ottawa Heart Institute, Ontario, Canada (D.Y.S.F.).
• Trenk D Department of Cardiology & Angiology II, University Heart Center Freiburg-Bad Krozingen, Germany (D.T., W.H.).
• Alexopoulos D Second Department of Cardiology, National and Capodistrian University of Athens, Attikon University Hospital, Greece (D. Alexopoulos).
• Gurbel PA Inova Center for Thrombosis Research and Drug Development, Inova Heart and Vascular Institute, Falls Church, VA (P.A.G., U.S.T.).
• Hochholzer W Department of Cardiology & Angiology II, University Heart Center Freiburg-Bad Krozingen, Germany (D.T., W.H.).
• De Luca L Division of Cardiology, Laboratory of Interventional Cardiology, San Giovanni Evangelista Hospital, Tivoli-Rome, Italy (L.D.L.).
• Bonello L Assistance Publique-Hôpitaux de Marseille, Department of Cardiology, Hôpital Nord, Marseille, France (L.B.).
• Aradi D Heart Center Balatonfüred and Semmelweis University Budapest, Hungary (D. Aradi).
• Cuisset T Department of Cardiology, CHU Timone, and Aix-Marseille Université, Faculté de Médecine, Marseille, France (T.C.).
• Tantry US Inova Center for Thrombosis Research and Drug Development, Inova Heart and Vascular Institute, Falls Church, VA (P.A.G., U.S.T.).
• Wang TY Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (T.Y.W.).
• Valgimigli M Swiss Cardiovascular Center Bern, Bern University Hospital, Switzerland (M.V.).
• Waksman R Section of Interventional Cardiology, MedStar Washington Hospital Center, DC (R.W.).
• Mehran R Icahn School of Medicine at Mount Sinai, New York City, NY (R.M.).
• Montalescot G Sorbonne Université Paris 6, ACTION Study Group, Hôpital Pitié-Salpêtrière, France (G.M.).
• Franchi F Division of Cardiology, University of Florida College of Medicine, Jacksonville (D.J.A., F.R., F.F.).
• Price MJ Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, CA (M.J.P.).

Show more…

P2Y12 receptor inhibitors

drug interactions

hemorrhage

pharmacodynamics

platelet aggregation inhibitors

thrombosis

Administration, Intravenous

Administration, Oral

Aspirin

Clopidogrel

Consensus

Drug Substitution

Humans

Internationality

Platelet Aggregation Inhibitors

Purinergic P2Y Receptor Antagonists

Ticlopidine